Back to Search Start Over

Dissecting the heterogeneous cortical anatomy of autism spectrum disorder using normative models

Authors :
David Goyard
Tony Charman
Sarah Durston
Marianne Oldehinkel
Vincent Frouin
Sven Bölte
Andre F. Marquand
Christine Ecker
Simon Baron-Cohen
Mariam Zabihi
Christian F. Beckmann
Tobias Banaschewski
Jan K. Buitelaar
Rosemary Holt
Guillaume Dumas
Eva Loth
Declan G. Murphy
Thomas Wolfers
Julian Tillmann
Radboud University Medical Center [Nijmegen]
Donders Institute for Brain, Cognition and Behaviour
Radboud university [Nijmegen]
Service NEUROSPIN (NEUROSPIN)
Direction de Recherche Fondamentale (CEA) (DRF (CEA))
Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay
Institute of Psychiatry, Psychology & Neuroscience, King's College London
King‘s College London
Central Institute of Mental Health [Mannheim]
Medical Faculty [Mannheim]
Génétique humaine et fonctions cognitives - Human Genetics and Cognitive Functions (GHFC (UMR_3571 / U-Pasteur_1))
Institut Pasteur [Paris]-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS)
University of Cambridge [UK] (CAM)
University Medical Center [Utrecht]
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy
Goethe-Universität Frankfurt am Main
Stockholm County Council
Sackler Institute of Translational Neurodevelopment
Institute of Psychiatry, King's College London
Goethe-University Frankfurt am Main
Department of Psychiatry
The work is supported by the Netherlands Organization for Scientific Research VIDI Grant Nos. 016.156.415 (to AFM) and 864.12.003 (to CFB)
European Union Seventh Framework Programme Grant Nos. 602805 (AGGRESSOTYPE) (to JKB), 603016 (MATRICS) (to JKB), and 278948 (TACTICS) (to JKB)
European Community’s Horizon 2020 Programme (H2020/2014-2020) Grant Nos. 643051 (MiND) (to JKB) and 642996 (BRAINVIEW) (to JKB)
Wellcome Trust UK Strategic Award Grant No. 098369/Z/12/Z (to CFB)
and EU-AIMS (European Autism Interventions), which receives support from Innovative Medicines Initiative Joint Undertaking Grant No. 115300, the resources of which are composed of financial contributions from the European Union’s Seventh Framework Programme (Grant No. FP7/2007-2013), from the European Federation of Pharmaceutical Industries and Associations companies’ in-kind contributions.
JKB has been a consultant to, advisory board member of, and a speaker for Janssen Cilag BV, Eli Lilly, Shire, Lundbeck, Roche, and Servier. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents or royalties. CFB is director and shareholder in SBGNeuro Ltd. SB discloses that he has in the last 5 years acted as an author, consultant or lecturer for Shire, Medice, Roche, Eli Lilly, Prima Psychiatry, GLGroup, System Analytic, Ability Partner, Kompetento, Expo Medica, and Prophase. He receives royalties for text books and diagnostic tools from Huber/Hogrefe, Kohlhammer, and UTB. TB served in an advisory or consultancy role for Actelion, Hexal Pharma, Lilly, Lundbeck, Medice, Novartis, and Shire. He received conference support or speaker’s fee by Lilly, Medice, Novartis, and Shire. He has been involved in clinical trials conducted by Shire and Vifor Pharma. He received royalities from Hogrefe, Kohlhammer, CIP Medien, and Oxford University Press. The present work is unrelated to the above grants and relationships. The other authors report no biomedical financial interests or potential conflicts of interest.
We gratefully acknowledge the support of the EU-AIMS (European Autism Interventions) Longitudinal European Autism Project study team for data acquisition, quality control, and preprocessing.
European Project: 602805,EC:FP7:HEALTH,FP7-HEALTH-2013-INNOVATION-1,AGGRESSOTYPE(2013)
European Project: 603016,EC:FP7:HEALTH,FP7-HEALTH-2013-INNOVATION-1,MATRICS(2014)
European Project: 278948,EC:FP7:HEALTH,FP7-HEALTH-2011-two-stage,TACTICS(2012)
European Project: 643051,H2020,H2020-MSCA-ITN-2014,MiND(2015)
European Project: 115300,EC:FP7:SP1-JTI,IMI-JU-03-2010,EU-AIMS(2012)
Radboud University [Nijmegen]
Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA))
Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)
University Hospital Mannheim | Universitätsmedizin Mannheim
Institut Pasteur [Paris] (IP)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS)
Sackler Institute of Translational Neurodevelopment [London]
Source :
Biological Psychiatry : Cognitive Neuroscience and Neuroimaging, 4, 567-578, Zabihi, M, Oldehinkel, M, Wolfers, T, Frouin, V, Goyard, D, Loth, E, Charman, T, Tillmann, J, Banaschewski, T, Dumas, G, Holt, R, Baron-Cohen, S, Durston, S, Bölte, S, Murphy, D, Ecker, C, Buitelaar, J K, Beckmann, C F & Marquand, A F 2019, ' Dissecting the heterogeneous cortical anatomy of autism spectrum disorder using normative models ', Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, vol. 4, no. 6, pp. 567-578 . https://doi.org/10.1016/j.bpsc.2018.11.013, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, Elsevier, In press, ⟨10.1016/j.bpsc.2018.11.013⟩, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2019, 4 (6), pp.567-578. ⟨10.1016/j.bpsc.2018.11.013⟩, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, Elsevier, 2019, 4 (6), pp.567-578. ⟨10.1016/j.bpsc.2018.11.013⟩, Biological Psychiatry. Cognitive Neuroscience and Neuroimaging, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 4(6), 567. Elsevier Inc., Biological Psychiatry : Cognitive Neuroscience and Neuroimaging, 4, 6, pp. 567-578
Publication Year :
2019

Abstract

BackgroundThe neuroanatomical basis of autism spectrum disorder (ASD) has remained elusive, mostly due to high biological and clinical heterogeneity among diagnosed individuals. Despite considerable effort towards understanding ASD using neuroimaging biomarkers, heterogeneity remains a barrier, partly because studies mostly employ case-control approaches, which assume that the clinical group is homogeneous.MethodsHere, we used an innovative normative modelling approach to parse biological heterogeneity in ASD. We aimed to dissect the neuroanatomy of ASD by mapping the deviations from a typical pattern of neuroanatomical development at the level of the individual and to show the necessity to look beyond the case-control paradigm to understand the neurobiology of ASD. We first estimated a vertex-wise normative model of cortical thickness development using Gaussian process regression, then mapped the deviation of each participant from the typical pattern. For this we employed a heterogeneous cross-sectional sample of 206 typically developing (TD) individuals (127 male), and 321 individuals (232 male) with ASD (aged 6-31).ResultsWe found few case-control differences but the ASD cohort showed highly individualized patterns of deviations in cortical thickness that were widespread across the brain. These deviations correlated with severity of repetitive behaviors and social communicative symptoms, although only repetitive behaviors survived corrections for multiple testing.ConclusionsOur results: (i) reinforce the notion that individuals with ASD show distinct, highly individualized trajectories of brain development and (ii) show that by focusing on common effects (i.e. the ‘average ASD participant’), the case-control approach disguises considerable inter-individual variation crucial for precision medicine.

Details

ISSN :
24519022
Database :
OpenAIRE
Journal :
Biological Psychiatry : Cognitive Neuroscience and Neuroimaging, 4, 567-578, Zabihi, M, Oldehinkel, M, Wolfers, T, Frouin, V, Goyard, D, Loth, E, Charman, T, Tillmann, J, Banaschewski, T, Dumas, G, Holt, R, Baron-Cohen, S, Durston, S, Bölte, S, Murphy, D, Ecker, C, Buitelaar, J K, Beckmann, C F & Marquand, A F 2019, ' Dissecting the heterogeneous cortical anatomy of autism spectrum disorder using normative models ', Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, vol. 4, no. 6, pp. 567-578 . https://doi.org/10.1016/j.bpsc.2018.11.013, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, Elsevier, In press, ⟨10.1016/j.bpsc.2018.11.013⟩, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2019, 4 (6), pp.567-578. ⟨10.1016/j.bpsc.2018.11.013⟩, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, Elsevier, 2019, 4 (6), pp.567-578. ⟨10.1016/j.bpsc.2018.11.013⟩, Biological Psychiatry. Cognitive Neuroscience and Neuroimaging, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 4(6), 567. Elsevier Inc., Biological Psychiatry : Cognitive Neuroscience and Neuroimaging, 4, 6, pp. 567-578
Accession number :
edsair.doi.dedup.....ee366d62e3c620b3dd13aa96481007a4